Publications by authors named "E Van Obberghen"

Aim: Patients with chronic non-cancer pain are referred to pain centres to improve their pain treatment. The discontinuation of pain medications in case of poor efficacy can be difficult to accept for patients, particularly opioid analgesics. Previous research has described that from the patients' perspective, the psychological relief of a negative effect of chronic pain and withdrawal symptoms of prescription opioids represent drivers of persistent use and first stage of opioid use disorder, despite insufficient pain relief.

View Article and Find Full Text PDF

Background: Randomized clinical trials have demonstrated efficacy and safety of erenumab. The aim of this study is to evaluate the effectiveness and safety of erenumab in a real-world setting in French patients with migraine associated with extreme unmet needs.

Methods: This is a one year-prospective real-word study with enrolment of all consecutive adult patients included in the FHU InovPain registry who participated in a compassionate erenumab use program.

View Article and Find Full Text PDF

Migraine constitutes the world's second-leading cause of disability. Triptans, as serotonin 5-HT receptor agonists, remain the first-line treatment, despite discouraged use in individuals at high cardiovascular risk. Lasmiditan, a selective lipophilic 5-HT agonist without vasoconstrictive effects, is an emerging option.

View Article and Find Full Text PDF
Article Synopsis
  • Parosmia is a condition where the sense of smell is distorted, linked to various causes including infections and medications.
  • A study analyzed data from the WHO pharmacovigilance database, identifying 14,032 cases of parosmia, primarily in patients around 53 years old, with a notable number connected to COVID-19 vaccines.
  • The research found significant associations between parosmia and certain drug classes, particularly corticosteroids, antibiotics, nicotine dependence treatments, and some vaccines, suggesting a need to monitor these medications for potential side effects.
View Article and Find Full Text PDF

Na/H exchangers are membrane transporters conserved in all living systems and therefore are assumed to be amongst the most ancestral molecular devices that equipped the first protocells. Following the cloning and sequencing of its gene, the mammalian NHE1, that regulates pH and volume in all cells, has been thoroughly scrutinized by molecular and biochemical analyses. Those gave a series of crucial clues concerning its topology, dimeric organization, pharmacological profile, regulation, and the role of key amino acids.

View Article and Find Full Text PDF